Navigation Links
Knee Pain? An Exclusive Study Engineers Cartilage to Match Patient's Own Tissue
Date:1/8/2008

MINNEAPOLIS, Jan. 8 /PRNewswire/ -- Patients with knee cartilage injuries now have the opportunity to re-grow their cartilage as part of an innovative study at TRIA Orthopaedic Center, in Bloomington, MN. Cartilage is the tough but flexible tissue that covers the ends of your bones at a joint such as the knee; symptoms of knee cartilage defects include pain, swelling and catching. In the United States alone, knee pain ranks the second highest source of musculoskeletal-related physician visits in 2005, according to the National Ambulatory Medical Care Survey. This new implant technology, NeoCart(R), regenerates this injury-prone tissue within a bio-engineered material, grown from the patient's own cartilage cells. The matrix matches his or her unique cartilage characteristics, and is being studied as an alternative to a standard therapy called microfracture. Dr. Brad Nelson, Orthopaedic Surgeon and Principal Investigator for TRIA, will be implanting this engineered tissue matrix for a select number of patients.

Histogenics Corporation, makers of NeoCart(R), successfully completed Phase I of the NeoCart(R) clinical trial, demonstrating the safety of the technique in a small number of patients, and is now in Phase II, where NeoCart(R) will be compared with a standard therapy called microfracture. TRIA Orthopaedic Center is one of a limited number of sites in the country, and the only site in Minnesota, chosen to participate in the study. "We are thrilled to be one of five centers nationally participating in this clinical trial," said Ryan Graver, Director of Research and education for TRIA. "This kind of cutting-edge research improves Orthopaedic treatments and outcomes that our patients can expect. Our commitment is to improve care for all Orthopaedic patients and it is through such projects TRIA is beginning to translate science into advancements in clinical care."

Since the body does not naturally re-grow cartilage without medical intervention t
'/>"/>

SOURCE TRIA Orthopaedic Center
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine technology :

1. Dendreon Announces Publication of Phase 1 Study Highlighting Immunologic and Clinical Activity of Lapuleucel-T (Neuvenge(R)) in Advanced Breast Cancer Patients
2. EDAP Announces Launch of Clinical Study Combining HIFU and Chemotherapy for Localized Aggressive High Risk Prostate Cancer
3. Cephalon Announces Positive Results from a Pivotal Study of FENTORA in Opioid-tolerant Patients with Non-cancer Breakthrough Pain
4. Allos Therapeutics Initiates Study of PDX in Patients with Cutaneous T-Cell Lymphoma
5. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
6. Potential Safety Issue Identified in Ongoing Phase 2 Clinical Study of HCV-796
7. Study Suggests High-Dose Fish Oil May Significantly Improve Behavior in Children with ADHD
8. MicroDose Announces Positive Results From the QDose Inhaled Insulin Glucose Clamp Study
9. Video: Landmark Study in The Lancet: Patients Treated With Betaseron(R) After First MS Attack Experienced Significant Delay in MS Progression
10. MacroGenics Begins Global Phase 2/3 Protege Study in Recent-onset Type 1 Diabetes Mellitus
11. Sarasotas Roskamp Institute Releases Study Defining a Mechanism for Development of Obesity and the Metabolic Syndrome, Forerunners of Type 2 Diabetes

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/24/2009)...MOUNTAINVIEW,Calif.,Nov.24/PRNewswire/--SatelliteH...ofkidneydialysisservicesandamajorsponsorofnephrolo...asesurvivorandchefEliasNasrallahinhisefforttosuppo... EliasNasrallahbuiltasuccessfulcareerasachefforthe...fiveyearsago,whenhewasdiagnosedwithEndStageRenalDi...
(Date:11/24/2009)...SANDIEGO,Nov.24/PRNewswire-FirstCall/--OptimerPhar...tatthe21stAnnualPiperJaffrayHealthCareConferenceat...0p.m.EasternTime. ,, (Logo: http://www.newscom....eaudiowebcastofthispresentationwillbeaccessibleont...rpharma.com .Replaysofthispresentationwillbeavail...
(Date:11/24/2009)...LYNBROOK,N.Y.,Nov.24/PRNewswire-FirstCall/--BioSpe...euticalcompanydevelopingfirstinclasscollagenase-ba...nt,TomWegman,willpresentattheupcomingPiperJaffray2...009,at3:30pmETatTheNewYorkPalaceHotelinNewYork,NY....nder"CalendarofEvents"intheInvestorRelationssectio...
Breaking Medicine Technology:Satellite Healthcare and Renal Disease Survivor Elias Nasrallah Join Forces to Support the Homeless This Holiday Season 2American Association of Oral and Maxillofacial Surgeons Says Only Trained Dental and Medical Practitioners Should Administer and Monitor Anesthesia 53644 1American Association of Oral and Maxillofacial Surgeons Says Only Trained Dental and Medical Practitioners Should Administer and Monitor Anesthesia 53644 2Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 1Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 2Access to Americas Orthopaedic Services Act of 2009 Introduced in the Senate 53642 3Pennsylvania Department of Aging Seeks Consumer Input on New Health Care Option 53640 1Pennsylvania Department of Aging Seeks Consumer Input on New Health Care Option 53640 2
...lopment and,manufacturing organization for sterile...nancial partner to help it expand operations to me...es. , Isogen has previously announced a succ...d the opening of its first filling line facility i...ss, facility and capacity needs of the $2,billion ...
...: VICL ) today announced an exclusive, binding l... A.S. (EIP) for sales and marketing of the company...date in Turkey and the Turkish,Republic of Norther...egulatory,approvals for the territory and to pay V...ed transfer price in exchange for the rights to an...
Other Medicine Technology:Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 2Isogen Retains Strategic Partner Sheridan Road Financial to Meet Global Biopharma Demand 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 2Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 3Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 4Vical Signs Binding Letter of Intent for Sales and Marketing of Allovectin-7(R) in Turkey 5
(Date:11/24/2009)...e-USNewswire/--Parties,familydinners,andothergathe...Butthemerrimentcanchangetomiseryiffoodmakesyouorot...in/prnh/20090824/FDALOGO ) ,, Typicalsymptomsof...mptoms,whichcanstartanywherefromhourstodaysafterco...ewsisthatpracticingfourbasicfoodsafetymeasurescanh...
(Date:11/24/2009)...ear-endapproaches,manyemployeesarefacedwithanarray...takeadvantageofthesespecialtax-savingopportunities...highlightsthefollowingkeyyear-endplanningconsidera...ccounts(HealthFSAs) . Manyemployeestakeadvantage...heiremployer,shealthFSA.Theseemployeessavetaxesbyu...
(Date:11/24/2009)...ateFraternalOrderofPolicedistributedturkeys,canned...,, PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNewswire...nershipwiththeNewYorkStateFraternalOrderofPolice,h...York,sChildDevelopmentCenter,ProjectDiscoveryinPor...receivefreeturkeys,ham,chickenandothertrimmingstop...
(Date:11/24/2009)...ause of inflammatory bowel disease is largely unkn...g 2009 Advances in Inflammatory Bowel Diseases, th...linical & Research Conference, December 3-6 in... mutation for Crohn’s disease. , ...09 -- The molecular cause of inflammatory bowel di...
(Date:11/24/2009)...NIP,Inc.todayannouncedtheacquisitionofRetirementCa...compensationandbenefitplanprovidersheadquarteredin...es,Milwaukee,Boston,ChicagoandAtlanta.RCGwasfounde...utivebenefitsindustry. ,, "Weareexcitedtoannoun...ketpresence,"statesBillPollock,ChairmanandFoundero...
Breaking Medicine News(10 mins):Health News:FDA Consumer Health Information: Food Safety Tips for Healthy Holidays 2Health News:The Right Tax Moves for Employees to Make Before Year-End 2Health News:The Right Tax Moves for Employees to Make Before Year-End 3Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 2Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 3Health News:Researchers Identify Possible Causative Mutation for Crohn's Disease: Crohn's & Colitis Foundation Annual Conference to Present Emerging Research 4Health News:NIP Acquires San Diego Executive Benefits Firm 2
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
...laboratory and a worldwide leader in innovative la...extensive test menu of highly complex and unique m...wned by the University of Utah, ARUP Laboratories'...iversity teaching hospitals and children's hospita...
Medicine Products: